NO995822D0 - Sulfate salt of an HIV protease inhibitor which has improved oral absorption and bioavailability - Google Patents
Sulfate salt of an HIV protease inhibitor which has improved oral absorption and bioavailabilityInfo
- Publication number
- NO995822D0 NO995822D0 NO995822A NO995822A NO995822D0 NO 995822 D0 NO995822 D0 NO 995822D0 NO 995822 A NO995822 A NO 995822A NO 995822 A NO995822 A NO 995822A NO 995822 D0 NO995822 D0 NO 995822D0
- Authority
- NO
- Norway
- Prior art keywords
- bioavailability
- protease inhibitor
- hiv protease
- sulfate salt
- oral absorption
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995822D0 true NO995822D0 (en) | 1999-11-26 |
| NO995822L NO995822L (en) | 2000-01-28 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995822A NO995822L (en) | 1997-05-29 | 1999-11-26 | Sulfate salt of an HIV protease inhibitor which has improved oral absorption and bioavailability |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (en) |
| JP (1) | JP3267632B2 (en) |
| KR (1) | KR20010013042A (en) |
| CN (1) | CN1257497A (en) |
| AU (1) | AU730245B2 (en) |
| BG (1) | BG103923A (en) |
| BR (1) | BR9809498A (en) |
| CA (1) | CA2291086A1 (en) |
| EA (1) | EA199901095A1 (en) |
| EE (1) | EE9900543A (en) |
| HR (1) | HRP980283A2 (en) |
| HU (1) | HUP0004621A3 (en) |
| ID (1) | ID23858A (en) |
| IL (1) | IL132779A0 (en) |
| IS (1) | IS5240A (en) |
| NO (1) | NO995822L (en) |
| PE (1) | PE75099A1 (en) |
| PL (1) | PL336847A1 (en) |
| SK (1) | SK163299A3 (en) |
| TR (1) | TR199902816T2 (en) |
| TW (1) | TW438799B (en) |
| WO (1) | WO1998054178A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514910A (en) | 1999-11-24 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | Gamma-hydroxy-2- (fluoroalkylaminocarbonyl) -1-piperazinepentanamides as HIV protease inhibitors |
| US20020082421A1 (en) * | 2000-09-14 | 2002-06-27 | Abdel-Magid Ahmed F. | Novel solid salt forms of N-[2-[4-[2-(1- methylethoxy)phenyl]-1-piperazinyl]-2-oxo-1piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0734387B1 (en) * | 1993-12-15 | 2002-04-10 | Merck & Co. Inc. | Hiv protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/en active
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 SK SK1632-99A patent/SK163299A3/en unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/en unknown
- 1998-05-26 IL IL13277998A patent/IL132779A0/en unknown
- 1998-05-26 JP JP50079999A patent/JP3267632B2/en not_active Expired - Fee Related
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/en not_active Application Discontinuation
- 1998-05-26 PL PL98336847A patent/PL336847A1/en unknown
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/en unknown
- 1998-05-26 CN CN98805372A patent/CN1257497A/en active Pending
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-26 EE EEP199900543A patent/EE9900543A/en unknown
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/en unknown
- 1998-05-26 EA EA199901095A patent/EA199901095A1/en unknown
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/en not_active Application Discontinuation
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/en not_active Application Discontinuation
- 1998-05-28 PE PE1998000432A patent/PE75099A1/en not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/en unknown
- 1999-11-24 BG BG103923A patent/BG103923A/en unknown
- 1999-11-26 NO NO995822A patent/NO995822L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0986554A1 (en) | 2000-03-22 |
| KR20010013042A (en) | 2001-02-26 |
| HRP980283A2 (en) | 1999-08-31 |
| BG103923A (en) | 2000-06-30 |
| IS5240A (en) | 1999-11-09 |
| HUP0004621A3 (en) | 2002-04-29 |
| EA199901095A1 (en) | 2000-08-28 |
| EE9900543A (en) | 2000-06-15 |
| AU7595998A (en) | 1998-12-30 |
| WO1998054178A1 (en) | 1998-12-03 |
| CN1257497A (en) | 2000-06-21 |
| IL132779A0 (en) | 2001-03-19 |
| JP3267632B2 (en) | 2002-03-18 |
| NO995822L (en) | 2000-01-28 |
| TR199902816T2 (en) | 2000-02-21 |
| JP2000513747A (en) | 2000-10-17 |
| TW438799B (en) | 2001-06-07 |
| CA2291086A1 (en) | 1998-12-03 |
| ID23858A (en) | 2000-05-25 |
| SK163299A3 (en) | 2000-07-11 |
| PL336847A1 (en) | 2000-07-17 |
| PE75099A1 (en) | 1999-08-11 |
| BR9809498A (en) | 2000-06-20 |
| HUP0004621A2 (en) | 2002-03-28 |
| AU730245B2 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04434B1 (en) | Bisulfate salt of HIV protease inhibitor | |
| PT1086076E (en) | SULFONAMIDE INHIBITORS OF ASPARTIL PROTEASE | |
| DK1070069T3 (en) | Bicyclic hydroxamic acid derivatives | |
| IS5340A (en) | Aryloxyarylsulfonylamino hydroxamic acid derivatives | |
| DE60101968D1 (en) | ALPHA CRYSTAL SHAPE OF PERINDOPRILE TERT BUTYLAMINE SALT | |
| NO993587D0 (en) | Sulfonamide metalloprotease inhibitors | |
| NO20011886L (en) | Forms of fexofenadine | |
| ATE230275T1 (en) | ANGIOGENSIS INHIBITOR | |
| NO974403D0 (en) | Reversible protease inhibitors | |
| PT1047450E (en) | ACE INHIBITOR COMBINATIONS - MMP INHIBITOR | |
| FI962073A0 (en) | Prodrug forms of the HIV protease inhibitor | |
| FI20000194A0 (en) | The method of trading | |
| EE04750B1 (en) | Method for the preparation of HIV protease inhibitors | |
| DE69908951D1 (en) | CRYSTAL FORMS OF OSANETANT | |
| NO995822D0 (en) | Sulfate salt of an HIV protease inhibitor which has improved oral absorption and bioavailability | |
| EE200100084A (en) | New pharmaceutical uses of NOS inhibitors | |
| DE29800292U1 (en) | Trinket | |
| DE29712586U1 (en) | Trinket | |
| DE29818455U1 (en) | Trinket | |
| DE29806370U1 (en) | Trinket | |
| DE29723230U1 (en) | Trinket | |
| DE29723217U1 (en) | Trinket | |
| DE29722096U1 (en) | Trinket | |
| ID20888A (en) | YEARS OF ORGANOLOGICAL PLABETIZATION | |
| NO994415D0 (en) | HIV protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |